JPRN-UMIN000010774已完成未知
Posttransplant Vorinostat therapy for the prevention of early relapse after allogeneic stem cell transplantation against mycosis fungoides/Sezary syndrome - Posttransplant Vorinostat therapy against mycosis fungoides/Sezary syndrome
orth Japan Hematology Study Group0 个研究点目标入组 6 人开始时间: 2013年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Diabetes uncontrollable (2)Uncontrollable hypertension. (3)Current active infection. (4)Hepatitis B virus antigen (HBsAg), Hepatitis C virus RNA, or HIV antibody- positive. (5)Current active cancer. (6)Pregnant or nursing women or women who may be pregnant. (7)Uncontrollable mental illness. (8)Other unsuitable reasons
研究者
相似试验
No Longer Available
不适用
Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)Lymphoma, T-Cell, CutaneousNCT00419367Merck Sharp & Dohme LLC
撤回
2 期
A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host DiseaseChronic Graft-Versus-Host DiseaseNCT01028313SCRI Development Innovations, LLC
已完成
1 期
Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal CancerColorectal CancerNCT00336141University of Southern California10
Unknown
1 期
Clinical Trial of SAHA in Patients With Breast CancerBreast CancerNCT00416130National University Hospital, Singapore49
已完成
2 期
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host DiseaseGraft Versus Host DiseaseNCT00074035Alliance for Clinical Trials in Oncology39